Utilization patterns and factors associated with persistence of new users of anti-osteoporosis treatment in Denmark: a population-based cohort study

SUMMARY: Persistence with initial treatment was highest after 1 year, decreasing afterwards. Persistence was highest for denosumab followed by alendronate. We identified several factors associated with treatment persistence, some of which were the same irrespective of OTx agent, which could help tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Alma B., Risbo, Nickolaj, Kafatos, George, Neasham, David, O’Kelly, James, Ehrenstein, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834110/
https://www.ncbi.nlm.nih.gov/pubmed/36629929
http://dx.doi.org/10.1007/s11657-023-01210-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834110/
https://www.ncbi.nlm.nih.gov/pubmed/36629929
http://dx.doi.org/10.1007/s11657-023-01210-4

Ejemplares similares